Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Bionano Genomics Inc (BNGO)

Bionano Genomics Inc (BNGO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,714,151
  • Shares Outstanding, K 153,186
  • Annual Sales, $ 10,130 K
  • Annual Income, $ -29,820 K
  • 60-Month Beta 2.33
  • Price/Sales 110.26
  • Price/Cash Flow N/A
  • Price/Book 111.81
Trade BNGO with:

Options Overview

Details
  • Implied Volatility 172.05%
  • Historical Volatility 133.23%
  • IV Percentile 32%
  • IV Rank 18.42%
  • IV High 246.43% on 01/28/21
  • IV Low 155.25% on 02/10/21
  • Put/Call Vol Ratio 0.18
  • Today's Volume 26,374
  • Volume Avg (30-Day) 57,290
  • Put/Call OI Ratio 0.48
  • Today's Open Interest 199,703
  • Open Int (30-Day) 229,373

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.05
  • Number of Estimates 2
  • High Estimate -0.05
  • Low Estimate -0.06
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.01%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.05 +34.53%
on 02/23/21
15.69 -30.98%
on 02/16/21
-1.75 (-13.91%)
since 01/25/21
3-Month
0.48 +2,156.25%
on 11/30/20
15.69 -30.98%
on 02/16/21
+10.34 (+2,114.72%)
since 11/25/20
52-Week
0.25 +4,232.00%
on 04/02/20
15.69 -30.98%
on 02/16/21
+9.77 (+921.70%)
since 02/25/20

Most Recent Stories

More News
BNGO Crosses Above Average Analyst Target

In recent trading, shares of BioNano Genomics Inc have crossed above the average analyst 12-month target price of $10.94, changing hands for $11.19/share. When a stock reaches the target an analyst has...

BNGO : 10.83 (-3.22%)
Thinking about buying stock in Nokia, BioNano Genomics, TJX Companies, Bank of America, or Advanced Micro Devices?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NOK, BNGO, TJX, BAC, and AMD.

BNGO : 10.83 (-3.22%)
AMD : 86.03 (-1.05%)
BAC : 36.78 (+1.10%)
NOK : 4.28 (+5.94%)
TJX : 69.49 (-0.53%)
Bionano Publishes Method for Identifying Genes Likely to Cause Neurological Diseases Based on a Model Developed by Lineagen to Improve Interpretation of Variants of Unknown Significance

Bionano Genomics, Inc. (Nasdaq: BNGO) announced the publication of a study by its Lineagen team that describes the first genome-wide model to assess and score nearly all protein-coding genes based on their...

BNGO : 10.83 (-3.22%)
Bionano (BNGO) to Report Q4 Earnings: What's in the Offing?

Bionano (BNGO) will provide updates on its revenues and earnings when it reports fourth-quarter and full-year 2020 results.

MRNA : 150.00 (+3.60%)
AVIR : 80.00 (+4.95%)
BNGO : 10.83 (-3.22%)
CSTL : 83.00 (-0.25%)
Bionano Genomics to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that company management will present virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference. Erik Holmlin, PhD,...

MHMNF : 54.5000 (unch)
BNGO : 10.83 (-3.22%)
Method for Solid Tumor Analysis with Saphyr Published by Penn State Institute for Personalized Medicine, Opening Largest Oncology Market to Optical Genome Mapping

Bionano Genomics, Inc. (Nasdaq: BNGO), announced the publication of a method for using optical genome mapping (OGM) to identify structural variants (SVs) that drive cancer in a wide variety of solid tumor...

BNGO : 10.83 (-3.22%)
Bionano Genomics, Inc. (BNGO) Gains As Market Dips: What You Should Know

Bionano Genomics, Inc. (BNGO) closed at $11.80 in the latest trading session, marking a +1.29% move from the prior day.

BNGO : 10.83 (-3.22%)
Largest Hospital Diagnostic Lab in Canada Pilots Bionano's Saphyr; Seeking to Convert 30-Year-Old Workflow Based on Multiple Technologies Into a Single, High-Resolution Assay to Transform Cancer Diagnosis

Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that its Saphyr system is being piloted by the University Health Network's (UHN) Laboratory Medicine Program (LMP) in Toronto. The LMP is the largest...

BNGO : 10.83 (-3.22%)
Presentation Recordings from Bionano's Next-Generation Cytogenomics Symposium, its Most Attended Event to Date, Now Available Online

Bionano Genomics, Inc. (Nasdaq: BNGO) announced that presentation recordings from its 5-day Next-Generation Cytogenomics Symposium, which took place from January 11 to 15 and featured 33 presentations...

BNGO : 10.83 (-3.22%)
Bionano Genomics, Inc. (BNGO) Stock Sinks As Market Gains: What You Should Know

Bionano Genomics, Inc. (BNGO) closed at $11.85 in the latest trading session, marking a -1.41% move from the prior day.

BNGO : 10.83 (-3.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

BioNano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The Company offers proprietary nanochannel chips, automated imaging instrument, integrated primary and secondary software, and application specific reagents. BioNano Genomics, Inc. is based in San...

See More

Key Turning Points

3rd Resistance Point 12.81
2nd Resistance Point 12.17
1st Resistance Point 11.68
Last Price 10.83
1st Support Level 10.55
2nd Support Level 9.91
3rd Support Level 9.42

See More

52-Week High 15.69
Last Price 10.83
Fibonacci 61.8% 9.79
Fibonacci 50% 7.97
Fibonacci 38.2% 6.15
52-Week Low 0.25

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar